LEAH CALDER: Open Payments
NPI 1063479608 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 36 payments from 11 companies in 2025. Trend: 2023 $2,146 · 2024 $1,462 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $175 |
| MERZ NORTH AMERICA, INC. | 1 | $152 |
| Novartis Pharmaceuticals Corporation | 8 | $146 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| Incyte Corporation | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $14 |
Products named: Xeomin, SKYRIZI, RINVOQ, COSENTYX, CIBINQO, EBGLYSS, DUPIXENT, Winlevi.
Industry payments across MS — which companies pay providers there.
